Pd. Sherrington et al., CLONAL EVOLUTION OF MALIGNANT AND NONMALIGNANT T-CELLS CARRYING T(1414) AND T(X14) IN PATIENTS WITH ATAXIA-TELANGIECTASIA, Oncogene, 9(8), 1994, pp. 2377-2381
People with ataxia telangiectasia (AT) are at a higher than normal ris
k of T cell leukaemia and often have either non-malignant or malignant
T cells with chromosomal abnormalities, typically t(14;14), inversion
14 or more rarely t(X;14). This provides a chance to study the pre-le
ukaemic phase of the disease. T cells have been studied with either t(
14;14)(q11;q32.1) or t(X;14)(q28;q11) from two AT sisters of which the
latter developed T cell leukaemia. The telomeric breakpoint of the t(
14;14) was cloned and found to occur at 14q32.1 where known tumour-ass
ociated breakpoints are located, but the patient remains asymptomatic
for leukaemia. Analysis of T cell populations in both patients showed
that the cells containing the translocation became oligoclonal with re
spect to T cell receptor beta rearrangement and complete T cell recept
or beta clonality was only established in the patient with t(X;14) by
onset of overt disease. Therefore in these chronic diseases, chromosom
al translocations can precede T cell receptor rearrangement suggesting
a role for these abnormalities as early events of malignant outgrowth
.